Preliminary Case Series Leads to New Questions About the Disease Progression of COVID-19 in Patients with Blood Clots in the Lung
A small, preliminary case series led by physicians at the Icahn School of Medicine at Mount Sinai found that five severely ill patients with the SARS-CoV-2 virus responded to the blood-clot-busting drug tPA when it was introduced as a life-saving measure....
Mount Sinai Turns Hundreds of Machines for Sleep Apnea into Hospital Ventilators, Shares Instructions Worldwide
A team of pulmonologists, anesthesiologists, sleep and critical care specialists, and medical students at the Mount Sinai Health System are reconfiguring hundreds of donated machines that are typically used at home for sleep apnea and deploying them as...
SARS-CoV2: How a Low-Powered Virus Turns Deadly
Early laboratory tests show the SARS-CoV2 virus, which leads to COVID-19, behaves very differently from the flu or common respiratory syncytial virus (RSV) in that it travels under the radar and enters human and animal cells quietly, eliciting a...
Mone Zaidi, MD, PhD, Receives a Lifetime Honor
Mone Zaidi, MD, PhD, Director of the Mount Sinai Bone Program, and Professor of Medicine (Endocrinology, Diabetes and Bone Disease) at the Icahn School of Medicine at Mount Sinai, has been named a Fellow of the American Association for the Advancement of...
Controlling Extreme Inflammation in Severe Cases of COVID-19 May Help Save Lives
Immunologists at the Icahn School of Medicine at Mount Sinai are playing a major role in managing the care of severely ill patients with COVID-19, who often experience an excessive inflammatory response to the disease that can ultimately overwhelm...
What Should Gastroenterologists and Patients Know About COVID-19?
Physicians need to consider that gastrointestinal (GI) symptoms, such as nausea, vomiting, and diarrhea could be early signs of COVID-19 infection, especially in those GI patients who also present with upper respiratory complaints. Meanwhile, patients with...
Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients
The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that...
Patients With COVID-19 Have Distinct Markings in Their Lungs, New Study Finds
Patients in China with COVID-19 showed distinct patterns in their lungs that became more defined within a few of days of disease onset, according to two cardiothoracic radiologists at the Mount Sinai Health System, who were the first in the nation to...
Team Identifies Path to Blood Test for Artery Disorder
A Mount Sinai team has gained valuable insights into fibromuscular dysplasia (FMD), a disorder of the arteries that is typically diagnosed in otherwise healthy women at midlife and sometimes causes aneurysms or serious heart disease. The findings could open the door...
